Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Epidemiology of primary sclerosing cholangitis in general and IBD populations: a systematic review and meta-analysis.

Hepatology international·2026

Same author

Characterizing Social Determinants of Health in Patients With Type 2 Diabetes and Liver Disease: Cross-Sectional Survey Study.

JMIR formative research·2026

Same author

Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.

Digestive diseases and sciences·2026

Same author

Systematic Review: Imaging-Based Morphological Criteria for Liver Cirrhosis-A Call to Standardise.

Alimentary pharmacology & therapeutics·2026

Same author

Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population.

Alimentary pharmacology & therapeutics·2026

Same author

Identifying Provider Prescribing Practices for GLP-1RAs and SGLT-2is in Patients With Type 2 Diabetes to Address Pharmacoinequity.

Journal of diabetes research·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Integrating PNPLA3 into clinical risk prediction.

Vincent L Chen¹, Umberto Vespasiani-Gentilucci^2,3

¹Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Liver International : Official Journal of the International Association for the Study of the Liver

|September 16, 2024

Summary

The PNPLA3 gene variant aids in predicting liver disease risk, particularly in high-risk populations. It refines risk stratification when combined with non-invasive tests for metabolic dysfunction-associated steatotic liver disease (MASLD).

Keywords:

APRI FIB‐4 VCTE genetics non‐invasive test precision medicine

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: Jun 13, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

Genetics
Hepatology
Clinical Risk Prediction

Background:

The PNPLA3-rs738409-G variant is linked to hepatic fat accumulation and MASLD progression.
Clinical application of this genetic discovery remains limited due to unclear added value in risk prediction.

Purpose of the Study:

To review evidence on integrating the PNPLA3 variant into diagnostic and risk stratification scores for liver diseases.
Focus on MASLD, but also consider other liver disease etiologies.

Main Methods:

Mini-review of existing scientific literature.
Analysis of PNPLA3 variant's role in diagnosing and predicting liver disease progression.
Evaluation of its integration with non-invasive tests like Fibrosis-4 and elastography.

Main Results:

PNPLA3 variant has minimal impact on diagnosing current liver disease state (steatohepatitis, fibrosis stage).
It enhances prediction of risk profiles, especially in populations with high pre-test probability for significant fibrosis.
Integration with FIB4 refines risk stratification for MASLD; its role in predicting hepatocellular carcinoma in cirrhosis is noted, but decompensation risk is less clear.

Conclusions:

The PNPLA3 variant is valuable for predicting liver disease risk, not diagnosing current disease state.
Its integration with existing scores can personalize monitoring and interventions for MASLD.
Further research is needed to clarify its role in predicting decompensation in cirrhosis.